Revenue: As of FY2026 Q1, the actual value is USD 96 K.EPS: As of FY2026 Q1, the actual value is USD -0.04.EBIT: As of FY2026 Q1, the actual value is USD -2.542 M.OneMedNet Corporation operates as a single segment, focusing on digital medical image management, exchange, and sharing solutions .<h4>Revenue by Product Offering</h4><ul><li>Subscription revenue (BEAM) decreased by -100% to $0 thousand for the three months ended March 31, 2026, from $58 thousand in the prior year period, due to the platform’s decommissioning in May 2025 .</li><li>Web imaging revenue (Real-World Data) increased by 22% to $96 thousand for the three months ended March 31, 2026, from $79 thousand in the prior year period, driven by growth in the customer base and higher data delivery volume .</li><li>Total Revenue decreased by -30% to $96 thousand for the three months ended March 31, 2026, from $137 thousand in the prior year period .</li></ul><h4>Revenue by Geographic Region</h4><ul><li>Americas revenue was $91 thousand for the three months ended March 31, 2026, compared to $119 thousand for the same period in 2025 .</li><li>Rest of World revenue was $5 thousand for the three months ended March 31, 2026, compared to $18 thousand for the same period in 2025 .</li><li>Total revenue was $96 thousand for the three months ended March 31, 2026, compared to $137 thousand for the same period in 2025 .</li></ul><h4>Operational Metrics</h4><ul><li>Cost of Revenue increased by 32% to $476 thousand for the three months ended March 31, 2026, from $361 thousand in the prior year, primarily due to increased data and curation charges .</li><li>Gross Margin was - $380 thousand for the three months ended March 31, 2026, compared to - $224 thousand in the prior year, representing a 70% increase in loss .</li><li>General and Administrative Expenses increased by 9% to $1,483 thousand for the three months ended March 31, 2026, from $1,362 thousand in the prior year, mainly due to increased share-based compensation expense .</li><li>Sales and Marketing Expenses increased by 30% to $378 thousand for the three months ended March 31, 2026, from $290 thousand in the prior year, driven by increased headcount for iRWD sales growth .</li><li>Research and Development Expenses decreased by -11% to $311 thousand for the three months ended March 31, 2026, from $348 thousand in the prior year .</li><li>Total Operating Expenses increased by 9% to $2,172 thousand for the three months ended March 31, 2026, from $2,000 thousand in the prior year .</li><li>Loss from Operations was - $2,552 thousand for the three months ended March 31, 2026, compared to - $2,224 thousand in the prior year, an increase in loss of 15% .</li><li>Net Loss increased by 29% to - $2,453 thousand for the three months ended March 31, 2026, from - $1,902 thousand in the prior year .</li></ul><h4>Cash Flow</h4><ul><li>Net Cash Used in Operating Activities was - $1,542 thousand for the three months ended March 31, 2026, compared to - $1,854 thousand in the prior year .</li><li>Net Cash Provided by Investing Activities was $352 thousand for the three months ended March 31, 2026, compared to $1,920 thousand in the prior year .</li><li>Net Cash Provided by (Used in) Financing Activities was $838 thousand for the three months ended March 31, 2026, compared to - $94 thousand in the prior year .</li></ul><h4>Unique Financial Metrics</h4><ul><li>Change in Fair Value of Crypto Assets – Bitcoin was - $102 thousand for the three months ended March 31, 2026, compared to $662 thousand in the prior year .</li><li>Realized Loss (Gain) on Sale of Crypto Assets – Bitcoin was $188 thousand for the three months ended March 31, 2026, compared to - $531 thousand in the prior year .</li><li>Change in Fair Value of SEPA Derivative Liabilities was - $179 thousand for the three months ended March 31, 2026, compared to - $324 thousand in the prior year .</li></ul><h4>Future Outlook and Strategy</h4>OneMedNet Corporation faces substantial doubt about its ability to continue as a going concern due to recurring net losses and insufficient cash for operations . The company plans to raise additional capital through equity or debt offerings and aims for profitable operations, while also addressing a Nasdaq non-compliance notice . Strategically, the company transitioned from its legacy BEAM platform in May 2025 to focus on a unified real-world data platform, which has driven growth in data deliveries .

OneMedNet | 10-Q: FY2026 Q1 Revenue: USD 96 K